ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/21 | 927 | 936 | 903 | 911 | -16 | -1.7% | 1,194,300 |
| 2024/02/20 | 927 | 940 | 924 | 927 | -1 | -0.1% | 845,600 |
| 2024/02/19 | 928 | 940 | 921 | 928 | -2 | -0.2% | 631,300 |
| 2024/02/16 | 916 | 941 | 907 | 930 | +29 | +3.2% | 926,000 |
| 2024/02/15 | 955 | 958 | 894 | 901 | -32 | -3.4% | 1,605,200 |
| 2024/02/14 | 974 | 978 | 933 | 933 | -55 | -5.6% | 1,443,100 |
| 2024/02/13 | 1,002 | 1,007 | 987 | 988 | -14 | -1.4% | 703,500 |
| 2024/02/09 | 1,011 | 1,011 | 994 | 1,002 | -8 | -0.8% | 493,600 |
| 2024/02/08 | 1,003 | 1,018 | 995 | 1,010 | +10 | +1% | 529,900 |
| 2024/02/07 | 1,009 | 1,023 | 997 | 1,000 | -8 | -0.8% | 594,100 |
| 2024/02/06 | 1,045 | 1,045 | 1,006 | 1,008 | -46 | -4.4% | 1,114,100 |
| 2024/02/05 | 1,059 | 1,063 | 1,044 | 1,054 | ±0 | ±0% | 694,600 |
| 2024/02/02 | 1,058 | 1,070 | 1,052 | 1,054 | -8 | -0.8% | 525,300 |
| 2024/02/01 | 1,085 | 1,088 | 1,059 | 1,062 | -33 | -3% | 689,500 |
| 2024/01/31 | 1,050 | 1,106 | 1,049 | 1,095 | +43 | +4.1% | 1,054,900 |
| 2024/01/30 | 1,041 | 1,065 | 1,038 | 1,052 | +22 | +2.1% | 1,113,800 |
| 2024/01/29 | 1,045 | 1,056 | 1,018 | 1,030 | -75 | -6.8% | 2,294,700 |
| 2024/01/26 | 1,120 | 1,120 | 1,097 | 1,105 | -16 | -1.4% | 828,100 |
| 2024/01/25 | 1,134 | 1,136 | 1,092 | 1,121 | -27 | -2.4% | 1,028,900 |
| 2024/01/24 | 1,152 | 1,167 | 1,145 | 1,148 | -2 | -0.2% | 337,900 |
| 2024/01/23 | 1,175 | 1,188 | 1,150 | 1,150 | -11 | -0.9% | 283,800 |
| 2024/01/22 | 1,156 | 1,170 | 1,149 | 1,161 | +10 | +0.9% | 326,500 |
| 2024/01/19 | 1,165 | 1,167 | 1,148 | 1,151 | -7 | -0.6% | 290,500 |
| 2024/01/18 | 1,165 | 1,167 | 1,144 | 1,158 | -13 | -1.1% | 447,900 |
| 2024/01/17 | 1,195 | 1,213 | 1,171 | 1,171 | -35 | -2.9% | 511,000 |
| 2024/01/16 | 1,201 | 1,219 | 1,199 | 1,206 | +3 | +0.2% | 307,500 |
| 2024/01/15 | 1,216 | 1,216 | 1,191 | 1,203 | -12 | -1% | 437,800 |
| 2024/01/12 | 1,224 | 1,228 | 1,198 | 1,215 | +1 | +0.1% | 323,000 |
| 2024/01/11 | 1,208 | 1,223 | 1,198 | 1,214 | +19 | +1.6% | 359,500 |
| 2024/01/10 | 1,165 | 1,200 | 1,158 | 1,195 | +40 | +3.5% | 407,800 |
| 2024/01/09 | 1,147 | 1,167 | 1,143 | 1,155 | +13 | +1.1% | 290,800 |
| 2024/01/05 | 1,177 | 1,178 | 1,142 | 1,142 | -44 | -3.7% | 462,000 |
| 2024/01/04 | 1,168 | 1,193 | 1,146 | 1,186 | +14 | +1.2% | 420,900 |
| 2023/12/29 | 1,179 | 1,188 | 1,164 | 1,172 | -5 | -0.4% | 247,100 |
| 2023/12/28 | 1,145 | 1,177 | 1,132 | 1,177 | +40 | +3.5% | 306,500 |
| 2023/12/27 | 1,114 | 1,139 | 1,101 | 1,137 | +17 | +1.5% | 441,000 |
| 2023/12/26 | 1,111 | 1,130 | 1,111 | 1,120 | +13 | +1.2% | 375,700 |
| 2023/12/25 | 1,120 | 1,125 | 1,098 | 1,107 | -15 | -1.3% | 375,200 |
| 2023/12/22 | 1,135 | 1,146 | 1,121 | 1,122 | +1 | +0.1% | 276,900 |
| 2023/12/21 | 1,132 | 1,144 | 1,117 | 1,121 | -20 | -1.8% | 343,500 |
| 2023/12/20 | 1,157 | 1,161 | 1,136 | 1,141 | -12 | -1% | 333,700 |
| 2023/12/19 | 1,145 | 1,155 | 1,136 | 1,153 | +13 | +1.1% | 271,200 |
| 2023/12/18 | 1,131 | 1,151 | 1,111 | 1,140 | -12 | -1% | 423,300 |
| 2023/12/15 | 1,174 | 1,180 | 1,142 | 1,152 | -18 | -1.5% | 418,200 |
| 2023/12/14 | 1,186 | 1,200 | 1,151 | 1,170 | ±0 | ±0% | 370,000 |
| 2023/12/13 | 1,165 | 1,184 | 1,149 | 1,170 | -1 | -0.1% | 337,400 |
| 2023/12/12 | 1,185 | 1,185 | 1,164 | 1,171 | -7 | -0.6% | 338,300 |
| 2023/12/11 | 1,183 | 1,203 | 1,168 | 1,178 | -4 | -0.3% | 411,200 |
| 2023/12/08 | 1,208 | 1,214 | 1,177 | 1,182 | -53 | -4.3% | 510,900 |
| 2023/12/07 | 1,257 | 1,269 | 1,233 | 1,235 | -23 | -1.8% | 330,800 |
51～
100
件表示中 / 6704件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 79,600円 | +32.2% | +84.6% | 2.51% | 13.61倍 | 1.77倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 鳥居薬 | 400,000円 | +7.3% | +16.8% | 3.00% | 23.93倍 | 0.94倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | 210,100円 | +6.8% | +18.7% | 2.09% | 13.23倍 | 1.22倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 199,500円 | -6.4% | -45.4% | 2.56% | 22.71倍 | 1.38倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| あすかＨＤ | 210,700円 | +2.6% | +5.1% | 1.90% | 9.62倍 | 1.02倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
